Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Journal of Zhejiang University. Medical sciences ; (6): 664-669, 2014.
Artículo en Chino | WPRIM | ID: wpr-251651

RESUMEN

<p><b>OBJECTIVE</b>To analyze the risk factors for biliary complications of liver transplantation from donation after cardiac death (DCD).</p><p><b>METHODS</b>Clinical data of 109 patients undergoing liver transplantation from DCD in First Affiliated Hospital of Zhejiang University School of Medicine from October 2010 to October 2013 were studied retrospectively. The risk factors of biliary complications following DCD liver transplantation were analyzed.</p><p><b>RESULTS</b>Twenty-four (22%) patients developed biliary complications after DCD liver transplantation. Univariate analysis showed that biliary complications were associated with warm ischemia time (P<0.001) and length of ICU stay (P=0.013), but not associated with ABO blood types match (P>0.05). Administration of inotropic agents and fatty liver increased the trend of biliary complications. Multivariate analysis demonstrated that warm ischemia time and length of ICU stay were independent risk factors for predicting biliary complications.</p><p><b>CONCLUSION</b>Warm ischemia time and days of ICU stay are independent risk factors for predicting biliary complications after DCD liver transplantation.</p>


Asunto(s)
Humanos , Enfermedades de las Vías Biliares , Epidemiología , Muerte , Tiempo de Internación , Trasplante de Hígado , Complicaciones Posoperatorias , Epidemiología , Estudios Retrospectivos , Factores de Riesgo , Factores de Tiempo , Isquemia Tibia
2.
Journal of Zhejiang University. Medical sciences ; (6): 670-677, 2014.
Artículo en Chino | WPRIM | ID: wpr-251650

RESUMEN

<p><b>OBJECTIVE</b>To investigate the risk factors associated with persistent thrombocytopenia after liver transplantation (LT), and to explore effective measures for prevention.</p><p><b>METHODS</b>One hundred and twenty-eight adult patients, who received liver transplantation in our hospital between January 2009 and June 2012 and met the inclusive criteria, were enrolled in the study. The clinical data were retrospectively analyzed, including pre-LT spleen volume, main portal vein size, coronary vein size, platelet and white blood cell levels, total bilirubin level and model of end stage liver disease score. The risk factors associated with persistent thrombocytopenia after LT were evaluated by logistic regression analysis. The effect of simultaneous splenic artery coarctation for high risk patients was evaluated with χ2 test.</p><p><b>RESULTS</b>Logistic regression analysis showed that per-LT spleen volume larger than 500 ml (P = 0.012, OR=2.789, 95%CI: 1.249-6.227) and portal vein size beyond 15 mm (P = 0.017, OR = 3.124, 95%CI: 1.230-7.933) were independent risk factors for persistent thrombocytopenia after LT. The incidence rate of persistent thrombocytopenia after LT in patients with or without simultaneous splenic artery coarctation were 16.7% (1/6) and 66.7% (32/48), respectively(P < 0.05).</p><p><b>CONCLUSION</b>Spleen volume larger than 500 ml and portal vein size beyond 15 mm are risk factors for persistent thrombocytopenia after LT. Simultaneous splenic artery coarctation may reduce the occurrence of persistent thrombocytopenia after LT.</p>


Asunto(s)
Adulto , Humanos , Trasplante de Hígado , Tamaño de los Órganos , Vena Porta , Estudios Retrospectivos , Factores de Riesgo , Bazo , Trombocitopenia , Epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA